J7-4635
MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy, 1. 10.2022-30.9.2026, Lucija Peterlin Mašič (FFA UL), Tina Kosjek (IJS)
MitoCan - Preclinical development of new Mitochondrial ion channel inhibitors for Cancer therapy, 1. 10.2022-30.9.2026, Lucija Peterlin Mašič (FFA UL), Tina Kosjek (IJS)